The interpretation of intradermal test results may improve if wheal erythema is measured objectively using colorimetry. Our aim was to find the necessary number of erythema colorimetric measurements, taken before and after intradermal injections of histamine 0.01% (H1), histamine 0.001% (H2), histamine 0.0001% (H3) and a negative control (NC). We also aimed to assess whether erythema should be measured at the wheal center or border, and to investigate whether erythema appears beyond histamine wheals (flare), as observed in humans. Duplicate injections of the four solutions were administered on the lateral thorax of seven healthy dogs and erythema was measured by removing and repositioning the colorimeter probe. Colorimetry can differentiate the change in erythema (ΔE) at the center (ΔEc), but not at the border, of the H1 wheals from the ΔE of NC and H3 wheals. Reliable ways to calculate ΔEc were to use the first positive a* axis value of the colorimeter before and after the injection or to obtain the first seven positive a* axis values, excluding the highest and lowest, and calculated the mean of the remaining five. Unlike in humans, intradermal injection of histamine, even at a concentration of 0.01%, did not induce a flare reaction in healthy dogs.
Ichthyoses are hereditary cornification disorders that manifest with abnormal differentiation and desquamation of keratinocytes in a form of generalized dry and scaly skin. In golden retriever dogs, autosomal recessive congenital ichthyosis (ARCI) has been associated with mutations in the PNPLA 1 gene. In human medicine, isotretinoin is frequently used to treat ARCIs. The aim of this study was to investigate the clinical and histological effects of isotretinoin on ARCI in a golden retriever dog with confirmed mutation in the PNPLA 1 gene. Clinical examination, blood analysis and histopathological examinations were conducted before and after 90 days of isotretinoin therapy. The clinical and histopathological findings indicate that treatment with oral isotretinoin was effective in improving ichthyosis without any side-effects.
Background: Currently used methods for the interpretation of intradermal allergen test results either ignore the erythema of the wheals (objective method) or evaluate it subjectively (subjective method, and global wheal score [GWS]). Objectives: To compare the efficacy of GWSs in differentiating between wheals induced by intradermal injection of a negative control and histamine at three different concentrations, using either the objective colorimetric measurement of erythema or the subjective evaluation of erythema as absent, weak, or strong. Animals: Seven clinically healthy dogs. Materials and Methods: Duplicate intradermal injections of a negative control, histamine 0.0001%, histamine 0.001%, and histamine 0.01% were administered on the lateral thorax of the dogs. A colorimeter was used to measure erythema before and 15 min after the injection and, at the same time, three blinded investigators scored erythema subjectively. Results: The subtraction of the first colorimetric measurement of erythema obtained before intradermal injection from the first postinjection objective measurement ( Δ Efirst) outperformed three other objective measurement methods and yielded GWSs capable of differentiation among the four solutions with efficiencies comparable to those of GWSs based on subjective erythema assessment. However, the stronger correlation between the later and wheal diameters may indicate bias in the subjective evaluation of erythema. Conclusions and Clinical Relevance: A single colorimetric measurement of erythema before and after intradermal injection of a negative control and histamine at three different concentrations, followed by calculation of their difference, can replace the subjective evaluation of erythema for the calculation of GWSs and avoid possible bias.